These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22087278)

  • 41. Design, synthesis, and biological evaluation of novel dual FFA1 (GPR40)/PPARδ agonists as potential anti-diabetic agents.
    Li Z; Hu L; Wang X; Zhou Z; Deng L; Xu Y; Zhang L
    Bioorg Chem; 2019 Nov; 92():103254. PubMed ID: 31518760
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of a potent and selective free fatty acid receptor 1 (FFA1/GPR40) agonist with favorable physicochemical and in vitro ADME properties.
    Christiansen E; Urban C; Grundmann M; Due-Hansen ME; Hagesaether E; Schmidt J; Pardo L; Ullrich S; Kostenis E; Kassack M; Ulven T
    J Med Chem; 2011 Oct; 54(19):6691-703. PubMed ID: 21854074
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discovery of novel potent GPR40 agonists containing imidazo[1,2-a]pyridine core as antidiabetic agents.
    Ye Z; Liu C; Zou F; Cai Y; Chen B; Zou Y; Mo J; Han T; Huang W; Qiu Q; Qian H
    Bioorg Med Chem; 2020 Jul; 28(13):115574. PubMed ID: 32546302
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and biological evaluation of 3-aryl-3-(4-phenoxy)-propionic acid as a novel series of G protein-coupled receptor 40 agonists.
    Song F; Lu S; Gunnet J; Xu JZ; Wines P; Proost J; Liang Y; Baumann C; Lenhard J; Murray WV; Demarest KT; Kuo GH
    J Med Chem; 2007 Jun; 50(12):2807-17. PubMed ID: 17500511
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, synthesis, and evaluation of a series of novel phenylpropanoic acid derivatives agonists for the FFA1.
    Yang J; Gu E; Yan T; Shen D; Feng B; Tang C
    Chem Biol Drug Des; 2019 May; 93(5):900-909. PubMed ID: 30657643
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lack of GPR40/FFAR1 does not induce diabetes even under insulin resistance condition.
    Matsuda-Nagasumi K; Takami-Esaki R; Iwachidow K; Yasuhara Y; Tanaka H; Ogi K; Nakata M; Yano T; Hinuma S; Taketomi S; Odaka H; Kaisho Y
    Diabetes Obes Metab; 2013 Jun; 15(6):538-45. PubMed ID: 23331570
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery of new dual PPARγ-GPR40 agonists with robust antidiabetic activity: Design, synthesis and in combo drug evaluation.
    Hidalgo-Figueroa S; Navarrete-Vázquez G; Estrada-Soto S; Giles-Rivas D; Alarcón-Aguilar FJ; León-Rivera I; Giacoman-Martínez A; Miranda Pérez E; Almanza-Pérez JC
    Biomed Pharmacother; 2017 Jun; 90():53-61. PubMed ID: 28342366
    [TBL] [Abstract][Full Text] [Related]  

  • 48. G protein-coupled receptor (GPR)40-dependent potentiation of insulin secretion in mouse islets is mediated by protein kinase D1.
    Ferdaoussi M; Bergeron V; Zarrouki B; Kolic J; Cantley J; Fielitz J; Olson EN; Prentki M; Biden T; MacDonald PE; Poitout V
    Diabetologia; 2012 Oct; 55(10):2682-2692. PubMed ID: 22820510
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of berberine as a novel agonist of fatty acid receptor GPR40.
    Rayasam GV; Tulasi VK; Sundaram S; Singh W; Kant R; Davis JA; Saini KS; Ray A
    Phytother Res; 2010 Aug; 24(8):1260-3. PubMed ID: 20658575
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early insulin release effectively improves glucose tolerance: studies in two rodent models of type 2 diabetes mellitus.
    de Souza CJ; Gagen K; Chen W; Dragonas N
    Diabetes Obes Metab; 2001 Apr; 3(2):85-95. PubMed ID: 11298730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined Deletion of Free Fatty-Acid Receptors 1 and 4 Minimally Impacts Glucose Homeostasis in Mice.
    Croze ML; Guillaume A; Ethier M; Fergusson G; Tremblay C; Campbell SA; Maachi H; Ghislain J; Poitout V
    Endocrinology; 2021 Mar; 162(3):. PubMed ID: 33543237
    [TBL] [Abstract][Full Text] [Related]  

  • 52. GPR40 is necessary but not sufficient for fatty acid stimulation of insulin secretion in vivo.
    Latour MG; Alquier T; Oseid E; Tremblay C; Jetton TL; Luo J; Lin DC; Poitout V
    Diabetes; 2007 Apr; 56(4):1087-94. PubMed ID: 17395749
    [TBL] [Abstract][Full Text] [Related]  

  • 53. G-protein coupled receptor 40 agonists as novel therapeutics for type 2 diabetes.
    Choi YJ; Shin D; Lee JY
    Arch Pharm Res; 2014 Apr; 37(4):435-9. PubMed ID: 24234912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel free fatty acid receptor 1 (GPR40/FFAR1) agonist, MR1704, enhances glucose-dependent insulin secretion and improves glucose homeostasis in rats.
    Tsuda N; Kawaji A; Sato T; Takagi M; Higashi C; Kato Y; Ogawa K; Naba H; Ohkouchi M; Nakamura M; Hosaka Y; Sakaki J
    Pharmacol Res Perspect; 2017 Aug; 5(4):. PubMed ID: 28805970
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic Exposure to SCO-267, an Allosteric GPR40 Full Agonist, Is Effective in Improving Glycemic Control in Rats.
    Koyama R; Ookawara M; Watanabe M; Moritoh Y
    Mol Pharmacol; 2021 Apr; 99(4):286-293. PubMed ID: 33547250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. GPR120 suppresses adipose tissue lipolysis and synergizes with GPR40 in antidiabetic efficacy.
    Satapati S; Qian Y; Wu MS; Petrov A; Dai G; Wang SP; Zhu Y; Shen X; Muise ES; Chen Y; Zycband E; Weinglass A; Di Salvo J; Debenham JS; Cox JM; Lan P; Shah V; Previs SF; Erion M; Kelley DE; Wang L; Howard AD; Shang J
    J Lipid Res; 2017 Aug; 58(8):1561-1578. PubMed ID: 28583918
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GPR40 agonists for the treatment of type 2 diabetes: life after 'TAKing' a hit.
    Mancini AD; Poitout V
    Diabetes Obes Metab; 2015 Jul; 17(7):622-9. PubMed ID: 25604916
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Free fatty acid receptor 1 agonist, MR1704, lowers blood glucose levels in rats unresponsive to the sulfonylurea, glibenclamide.
    Tsuda N; Kawaji A; Takagi M; Higashi C; Nakamura M; Hosaka Y; Sakaki J
    Drug Dev Res; 2018 Feb; 79(1):16-21. PubMed ID: 29080222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. GPR40 is partially required for insulin secretion following activation of beta3-adrenergic receptors.
    Pang Z; Wu N; Zhang X; Avallone R; Croci T; Dressler H; Palejwala V; Ferrara P; Tocci MJ; Polites HG
    Mol Cell Endocrinol; 2010 Aug; 325(1-2):18-25. PubMed ID: 20416356
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insulinotropic effects of GPR120 agonists are altered in obese diabetic and obese non-diabetic states.
    Zhang D; So WY; Wang Y; Wu SY; Cheng Q; Leung PS
    Clin Sci (Lond); 2017 Feb; 131(3):247-260. PubMed ID: 27980130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.